Multinational and domestic pharmaceutical companies are getting ready to compete in the KRW 100 billion COPD treatment market
The size of the entire COPD (Chronic Obstructive Pulmonary Disease) treatment market is estimated at approximately KRW 100 billion, and the two leading products are Seretide(GSK) and Spiriva(Boehringer Ingelheim). The top 10 products, including the two products, are occupying approximately 75% sa...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
